In addition, we believe that the evaluation efficiency of KL-6 should be combined with the course events, and multi-point KL-6 data analysis may more accurately evaluate the trend of pulmonary fibrosis changes in COVID-19. The gene discussed is MUC1; the disease is COVID-19.